BR112012000281A2 - proteína quimérica. - Google Patents

proteína quimérica.

Info

Publication number
BR112012000281A2
BR112012000281A2 BR112012000281A BR112012000281A BR112012000281A2 BR 112012000281 A2 BR112012000281 A2 BR 112012000281A2 BR 112012000281 A BR112012000281 A BR 112012000281A BR 112012000281 A BR112012000281 A BR 112012000281A BR 112012000281 A2 BR112012000281 A2 BR 112012000281A2
Authority
BR
Brazil
Prior art keywords
chimeric protein
chimeric
protein
Prior art date
Application number
BR112012000281A
Other languages
English (en)
Other versions
BR112012000281A8 (pt
Inventor
Erica Bickerton
Maria Armesto
Paul Britton
Original Assignee
Animal Health Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Animal Health Inst filed Critical Animal Health Inst
Publication of BR112012000281A2 publication Critical patent/BR112012000281A2/pt
Publication of BR112012000281A8 publication Critical patent/BR112012000281A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR112012000281A 2009-07-07 2010-07-05 Proteína quimérica BR112012000281A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0911794.6A GB0911794D0 (en) 2009-07-07 2009-07-07 Chimaeric protein
PCT/GB2010/001293 WO2011004146A1 (en) 2009-07-07 2010-07-05 Chimaeric protein

Publications (2)

Publication Number Publication Date
BR112012000281A2 true BR112012000281A2 (pt) 2016-08-09
BR112012000281A8 BR112012000281A8 (pt) 2016-09-06

Family

ID=41022290

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012000281A BR112012000281A8 (pt) 2009-07-07 2010-07-05 Proteína quimérica

Country Status (10)

Country Link
US (1) US8828407B2 (pt)
EP (1) EP2451827B1 (pt)
CN (1) CN102574897B (pt)
BR (1) BR112012000281A8 (pt)
ES (1) ES2589057T3 (pt)
GB (1) GB0911794D0 (pt)
HU (1) HUE029073T2 (pt)
PL (1) PL2451827T3 (pt)
WO (1) WO2011004146A1 (pt)
ZA (1) ZA201200200B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103060325B (zh) * 2013-01-14 2015-01-07 韩健宝 抗猪流行性腹泻病毒pedv的反义核酸及肽核酸pna
CN104072592B (zh) * 2013-03-26 2016-12-28 复旦大学 对新型冠状病毒HCoV-EMC 2012感染具有抑制作用的多肽及其应用
GB201308057D0 (en) 2013-05-03 2013-06-12 Pirbright Inst The Protein
GB201310031D0 (en) * 2013-06-05 2013-07-17 Pirbright Inst The Cell
CN103394097A (zh) * 2013-06-09 2013-11-20 东北农业大学 猪传染性胃肠炎和流行性腹泻两联疫苗的引物及制备方法
GB201413020D0 (en) * 2014-07-23 2014-09-03 Pribright The Inst Coronavirus
CN104262488B (zh) * 2014-09-24 2017-07-28 普莱柯生物工程股份有限公司 一种融合蛋白及其疫苗组合物的制备与应用
GB201601498D0 (en) 2016-01-27 2016-03-09 Pirbright Inst The Coronavirus
CN112996537A (zh) * 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN112996536A (zh) * 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的h52 ibv疫苗
CN109943536B (zh) * 2019-03-26 2021-09-14 昆明理工大学 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法
CN114126645A (zh) * 2019-05-10 2022-03-01 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s1亚基
WO2020229249A1 (en) 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein
WO2020229257A1 (en) * 2019-05-10 2020-11-19 Boehringer Ingelheim Vetmedica Gmbh Attenuated ibv with extended cell culture and tissue tropism
CN110894217B (zh) * 2019-12-16 2021-07-13 中国农业大学 一种牛冠状病毒嵌合抗原以及检测牛冠状病毒抗体的胶体金免疫层析试纸卡
US10975126B1 (en) 2020-04-23 2021-04-13 King Faisal University MERS-CoV inhibitor peptides
CN111607003B (zh) * 2020-05-21 2022-08-23 上海百英生物科技有限公司 一种SARS-CoV-2 N/S1(RBD)重组蛋白及制备方法和应用
WO2022005214A1 (ko) * 2020-06-30 2022-01-06 포항공과대학교 산학협력단 코로나-19 바이러스의 스파이크 단백질의 에스터가수분해효소 활성을 이용한 코로나 바이러스 감염증 치료제 스크리닝 키트 및 상기 키트를 이용하여 스크리닝된 물질의 코로나 바이러스 감염증의 예방, 개선 또는 치료 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1610817T3 (pl) 2003-03-03 2010-05-31 Intervet Int Bv Wirus zakaźnego zapalenia oskrzeli ze zmienionym genem wypustek
CN100374460C (zh) * 2004-07-05 2008-03-12 华中农业大学 含有与鸡传染性支气管炎病毒特异性结合短肽的噬菌体及应用
CN1763085A (zh) * 2005-11-02 2006-04-26 浙江大学 鸡传染性支气管炎病毒s1重组蛋白抗原、制备方法及用途
CN101240289A (zh) * 2008-03-11 2008-08-13 四川大学 一种禽传染性支气管炎病毒S1基因与禽IL-2基因共表达DNA疫苗pIRES-S1/IL2

Also Published As

Publication number Publication date
US20120177675A1 (en) 2012-07-12
ZA201200200B (en) 2013-03-27
WO2011004146A1 (en) 2011-01-13
EP2451827B1 (en) 2016-06-15
CN102574897B (zh) 2015-03-11
US8828407B2 (en) 2014-09-09
CN102574897A (zh) 2012-07-11
EP2451827A1 (en) 2012-05-16
GB0911794D0 (en) 2009-08-19
BR112012000281A8 (pt) 2016-09-06
HUE029073T2 (en) 2017-02-28
ES2589057T3 (es) 2016-11-08
PL2451827T3 (pl) 2016-12-30

Similar Documents

Publication Publication Date Title
BR112012000281A2 (pt) proteína quimérica.
BRPI1009415A2 (pt) escova de dentes.
BR112012002226A2 (pt) anticorpos muc1.
BRPI1010301A2 (pt) composição.
BRPI1009789A2 (pt) desacoplador.
BRPI1009811A2 (pt) transmissão.
BRPI1015139A2 (pt) Bebida instantânea
FR2947376B1 (fr) Sectionneur.
IT1396487B1 (it) Convogliatore.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1016192A2 (pt) derivados de soxazol.
BRPI1008708A2 (pt) gastroscópio.
BRPI1011794A2 (pt) compartimento.
BRPI1008952A2 (pt) Composição herbicida.
FR2942385B1 (fr) Grille-pain.
FR2946497B1 (fr) Elagueuse autonome
IT1392420B1 (it) Lavastoviglie.
BR112012014495A2 (pt) cosmético de autonivelamento.
IT1396642B1 (it) Statore.
BRPI1008675A2 (pt) grânulos.
BRPI1009515A2 (pt) Complexos de proteínas/glicosinolatos eletrostáticos.
BRPI1007268A2 (pt) Combinações pesticidas.
IT1401345B1 (it) Bomboletta.
FR2943510B1 (fr) Ombrelle.
ITME20080002A1 (it) Filcomplex - potabilizzatore di acque.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: THE PIRBRIGHT INSTITUTE (GB)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]